دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The digital frontier: bringing one generation to the next
doi : 10.1016/S2213-8587(21)00270-9
Volume 9, Issue 11, November 2021, Page 725
Insulin analogues: two sides of the same coin
doi : 10.1016/S2213-8587(21)00271-0
Volume 9, Issue 11, November 2021, Page 725
Statins for Graves' orbitopathy: a new tool for prevention and treatment?
LuigiBartalenaaElianaPiantanidaaMaria LauraTandaa
doi : 10.1016/S2213-8587(21)00268-0
Volume 9, Issue 11, November 2021, Pages 726-727
Forecasting therapeutic responses by albuminuria and eGFR slope during the DAPA-CKD trial
Katherine RTuttleab
doi : 10.1016/S2213-8587(21)00265-5
Volume 9, Issue 11, November 2021, Pages 727-728
Impact of the COVID-19 pandemic on transgender and gender diverse health care
Claire MBurgessabcAbagail WBatchelderbdeColleen ASloanafMichaelIeongghCarl GStreedJrgi
doi : 10.1016/S2213-8587(21)00266-7
Volume 9, Issue 11, November 2021, Pages 729-731
Sherita Hill Golden: tackling the source of health disparities
RayCavanaugh
doi : 10.1016/S2213-8587(21)00215-1
Volume 9, Issue 11, November 2021, Page 732
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
GiuliaLanzollaMDa†ElenaSabiniMDa†MarenzaLeoMDaFrancescaMenconiMDaRobertoRocchiMDaAngelaSframeliMDbPaoloPiaggiPhDcProfMarcoNardiMDbProfClaudioMarcocciMDaProfMicheleMarinòMDa
doi : 10.1016/S2213-8587(21)00238-2
Volume 9, Issue 11, November 2021, Pages 733-742
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
ProfHiddo J LHeerspinkPhDabNielsJongsPhDaProfGlenn MChertowMDcAnna MariaLangkildeMDdProfJohn J VMcMurrayMDeRicardoCorrea-RotterMDfPeterRossingMDghC DavidSjöströmMDdBergur VStefanssonMDdRobert DTotoMDiProfDavid CWheelerMDbjTomGreenePhDkDAPA-CKD Trial Committees and Investigators
doi : 10.1016/S2213-8587(21)00242-4
Volume 9, Issue 11, November 2021, Pages 743-754
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
NielsJongsPhDaTomGreenePhDbProfGlenn MChertowMDcProfJohn J VMcMurrayMDdAnna MariaLangkildeMDeRicardoCorrea-RotterMDfPeterRossingMDghC DavidSjöströmMDeBergur VStefanssonMDeRobert DTotoMDiProfDavid CWheelerMDjkProfHiddo J LHeerspinkPhDakfor theDAPA-CKD Trial Committees and Investigators
doi : 10.1016/S2213-8587(21)00243-6
Volume 9, Issue 11, November 2021, Pages 755-766
Adrenal myelolipomas
JanCalissendorffPhDadCarl ChristoferJuhlinPhDbcProfAndersSundinPhDeIrinaBancosMDfHenrikFalhammarPhDad
doi : 10.1016/S2213-8587(21)00178-9
Volume 9, Issue 11, November 2021, Pages 767-775
Obesity in people living with type 1 diabetes
ProfBartVan der SchuerenMDabDarcyEllisPhDbRaquel NFaradjiMDcdEebaAl-OzairiMDeJonathanRosenPhDfProfChantalMathieuMDab
doi : 10.1016/S2213-8587(21)00246-1
Volume 9, Issue 11, November 2021, Pages 776-785
COVID-19 and metabolic disease: mechanisms and clinical management
CharlotteSteenblockPhDaProfPeter E HSchwarzMDacdProfBarbaraLudwigMDabcdeProfAndreasLinkermannMDaProfPaulZimmetMDfKonstantinKulebyakinPhDghProfVsevolod ATkachukDScghProfAlexander GMarkovDSciProfHendrikLehnertMDjProfMartin Hrab?de AngelisMDdklHannesRietzschMDaRoman NRodionovPhDaProfKamleshKhuntiMDmDavidHopkinsFRCPnProfAndreas LBirkenfeldMDanopqProfBernhardBoehmMDrsProfRichard I GHoltFRCPtProfJay SSkylerMDuProfJ HansDeVriesMDvwProfEricRenardMDxyProfRobert HEckelMDzProfK George M MAlbertiFRCPaaProfBrunoGelonezeMDabProfJuliana CChanMDacadProfJean ClaudeMbanyaMDaeHenry COnyegbutulemFWACPafAmbadyRamachandranMDagProfAbdulBasitFRCPahProfMohamedHassaneinFRCPaiGavinBewickPhDnProfGiatgen ASpinasMDeProfFelixBeuschleinMDeProfRüdigerLandgrafMDajProfFrancescoRubinoMDnakProfGeltrudeMingroneMDnalamProfStefan RBornsteinMDacden
doi : 10.1016/S2213-8587(21)00244-8
Volume 9, Issue 11, November 2021, Pages 786-798
